Author

Nina Dvorina

Cleveland ClinicORCID 0000-0002-0352-6636Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Assay:imaging· 1

Frequent Co-Authors

Danielle D. KishiD· 2 shared Karen S. KeslariD· 2 shared Robert L. FairchildiD· 2 shared William M. BaldwiniD· 2 shared Brian D. SoutherniD· 1 shared Chengsong ZhuiD· 1 shared Daigo OkadaiD· 1 shared Hidetoshi TsudaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Danielle D. KishORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NK Cells Effectively Mediating Antibody-Mediated Kidney Allograft Rejection Requires a Specific Activation Receptor and Graft Expression of the Ligand

Yuki Maruyama, Daigo Okada, Hidetoshi Tsuda, Danielle D. Kish, Karen S. Keslar, Nina Dvorina, William M. Baldwin, Robert L. Fairchild

This study shows that NK cell activation via NKG2D and graft Rae-1e ligand is essential for antibody-mediated kidney allograft rejection, even with high DSA levels.

bioRxiv · Mar 5, 2026 · PreprintImmunology

Inhibition of De Novo Autoantibody Production Attenuates Chronic Antibody-Mediated Rejection of Kidney Allografts Despite Maintenance of High Donor-Specific Antibody Titers

Yosuke Mitsui, Karen S. Keslar, Michael Nicosia, Danielle D. Kish, Nina Dvorina, Chengsong Zhu, Mitchell A. Olman, Brian D. Southern, William M. Baldwin, Robert L. Fairchild

The paper shows that inhibiting de novo autoantibody production reduces chronic antibody-mediated rejection of kidney allografts, even when donor-specific antibody titers remain high.

bioRxiv · Jun 11, 2025 · PreprintImmunology